Riskpilot← Back to searchSign inGet full accessAuricura AB
ABActiveOrg 5593403362Hantverksgatan 18 C Lgh 1301Medical specialists activities · NACE 8622Est. 20210 employees
Revenue 2025
SEK 279K
+55% vs 2024
EBITDA margin
-19.3%
-171% vs 2024
Equity ratio
-26.7%
Financial strength
Net profit 2025
SEK -53K
-191% vs 2024
| Revenue | SEK 279K | +55% |
| EBITDA | SEK -54K | -171% |
| Net profit | SEK -53K | -191% |
| Total assets | SEK 92K | -43% |
| Equity | SEK -24K | -126% |
| Employees | 0 | — |
Legal name
Auricura AB
Org number
5593403362
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
13 oktober 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolagets verksamhet skall bestå av läkarbehandlingar inom öron, näsa, hals samt konsultation, utbildning och behandling som kan exempelvis bedrivas på läkarmottagningar, privata praktiker, men kan också finnas i anslutning till vårdcentraler, samt konsultation i patientens hem samt hyra ut sig själv som specialistläkare till öppen- och slutenvårdsmottagningar på sjukhus samt därmed förenlig verksamhet.
Address
Hantverksgatan 18 C Lgh 1301
Email
berner.attila@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 225 | 180 | 279 |
| Staff expenses | −3 | −0 | −210 |
| EBITDA | 91 | 76 | −54 |
| Depreciation & amort. | — | — | — |
| EBIT | 91 | 76 | −54 |
| Net financials | −1 | −1 | 1 |
| Profit before tax | 90 | 75 | −53 |
| Tax | −20 | −16 | — |
| Net profit | 70 | 58 | −53 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 266 | 162 | 92 |
| Equity | 95 | 93 | −24 |
| Long-term debt | — | — | — |
| Short-term debt | 171 | 68 | 116 |
| Total debt | 171 | 68 | 116 |
EBITDA margin
-19.3%
This company
15.8%
Market median
-222% vs market
20232025
Equity ratio
-26.7%
This company
38.2%
Market median
-170% vs market
20232025
Return on equity
-5292600.0%
This company
18.4%
Market median
-28764230% vs market
20232025
Net profit margin
-19.0%
This company
8.1%
Market median
-335% vs market
20232025
Asset turnover
3.04×
This company
1.12×
Market median
+171% vs market
20232025
Debt / equity
4.75×
This company
0.62×
Market median
-666% vs market
20232025
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Auricura AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sara Kristina Charlott Sjöholm | Deputy Board Member | 0 companies |
| Krisztina Fulop | Deputy Board Member | 0 companies |
| Attila Laszlo Berner | Board of Directors | 0 companies |